It belongs to a novel class of drugs known as triple agonists, meaning it simultaneously activates three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
(source: prnewswire.com) February 2025: Novo Nordisk announced that the FDA officially declared the shortages of Wegovy and Ozempic resolved, confirming that supply in the U.S
However, Meek said she has received reports from patients about issues with GLP-1s and birth control
The three most important things to remember here are 1
What sets our approach apart
But the fiscal cost on state Medicaid budgets would have been substantial, Jack Rollins, MPH, director of federal policy at the National Association of Medicaid Directors told The Nations Health